We’re located in Miami, Fl with a second state of the art manufacturing plant in Elkhart, Indiana. Our distribution facilities in Arlington, Texas, and Los Angeles, California, are strategically positioned to serve all of our customers in a timely and satisfied manner.
Another critical component of our business and marketing model is to develop long term "partnerships' with our customers. It's all about building and maintaining solid business relationships,
mutually and equitably fulfilling to all involved.
Applied Plasmonics, a fabless semiconductor company, has invented a practical, mass-market use for devices based on surface plasmons. The new technology employs nano-antennas manufactured in a single layer to generate visible light.
NanoSight delivers the world’s most versatile and proven multi-parameter nanoparticle analysis in a single instrument.
NanoSight visualizes, measures and characterizes virtually all nanoparticles. Particle size, concentration, zeta potential and aggregation can all be analyzed while a fluorescence mode provides speciation of labeled particles. NanoSight provides real time monitoring of the subtle changes in the characteristics of particle populations with all of these analyses uniquely confirmed by visual validation.
Nanolab, Inc is a private company categorized under Carbon Specialties for Electrical Use. We manufacture carbon nanotubes and develop nanoscale devices. NanoLab was founded in January 2000. The company is headquartered in Waltham, Massachusetts (was in Newton, Massachusetts).
Nanopartz is a division of Concurrent Analytical Inc. The purpose of Concurrent Analytical Inc. is to commercialize the Ramanprobes technology to revolutionize point of care diagnostics. Nanopartz commercializes gold nanoparticles, particularly gold nanorods, for the research market. Specifically, the mission of Nanopartz is to commercialize therapeutic, imaging, and materials applications of newly patent pending, patented, or proprietary technologies in gold nanoparticles and gold nanorods for the life science and non-life science research markets.